Amarantus Bioscience Holdings Inc (AMBS)

[BBalls-N-CowTown]

Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan indications and neurology, today announced that it will be presenting at the 2015 Aegis Growth Conference being held October 7-9, 2015 in Las Vegas, Nevada.


Gerald E. Commissiong, President & CEO of Amarantus, will present a corporate update on Friday, October 9, 2015 at 11:25 a.m. PDT.

As part of his presentation, Mr. Commissiong will discuss the Company’s recently announced strategic focus on the near-term development efforts for its Engineered Skin Substitute (ESS) program as a treatment for rare pediatric diseases, including pediatric severe burns and Congenital Giant Hairy Nevus.